Clark NP - Search Results

1

Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation.

Derington CG, Goodrich GK, Xu S, Clark NP, Reynolds K, An J, Witt DM, Smith DH, O'Keeffe-Rosetti M, Lang DT, Ho PM, Cheetham TC, Comer AC, King JB. Derington CG, et al. Among authors: clark np. JAMA Netw Open. 2023 Jul 3;6(7):e2321971. doi: 10.1001/jamanetworkopen.2023.21971. JAMA Netw Open. 2023. PMID: 37410461 Free PMC article.

2

A descriptive evaluation of unfractionated heparin use during pregnancy.

Clark NP, Delate T, Witt DM, Parker S, McDuffie R. Clark NP, et al. J Thromb Thrombolysis. 2009 Apr;27(3):267-73. doi: 10.1007/s11239-008-0207-0. Epub 2008 Mar 8. J Thromb Thrombolysis. 2009. PMID: 18327536

3

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium. Clark NP, et al. Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960. Pharmacotherapy. 2008. PMID: 18657012

4

Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.

Witt DM, Delate T, Clark NP, Martell C, Tran T, Crowther MA, Garcia DA, Ageno W, Hylek EM; Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium. Witt DM, et al. Among authors: clark np. Blood. 2009 Jul 30;114(5):952-6. doi: 10.1182/blood-2009-02-207928. Epub 2009 May 13. Blood. 2009. PMID: 19439733 Free article.

5

Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy.

Clark NP, Delate T, Cleary SJ, Witt DM. Clark NP, et al. Thromb Res. 2010 May;125(5):402-5. doi: 10.1016/j.thromres.2009.07.014. Epub 2009 Aug 21. Thromb Res. 2010. PMID: 19699510

6

Unfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancy.

Clark NP, Delate T, Cleary SJ, Witt DM. Clark NP, et al. Pharmacotherapy. 2010 Apr;30(4):369-74. doi: 10.1592/phco.30.4.369. Pharmacotherapy. 2010. PMID: 20334457

7

Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis.

Dentali F, Marchesi C, Giorgi Pierfranceschi M, Crowther M, Garcia D, Hylek E, Witt DM, Clark NP, Squizzato A, Imberti D, Ageno W. Dentali F, et al. Among authors: clark np. Thromb Haemost. 2011 Sep;106(3):429-38. doi: 10.1160/TH11-01-0052. Epub 2011 Jul 28. Thromb Haemost. 2011. PMID: 21800002

8

Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.

Witt DM, Delate T, Garcia DA, Clark NP, Hylek EM, Ageno W, Dentali F, Crowther MA. Witt DM, et al. Among authors: clark np. Arch Intern Med. 2012 Oct 22;172(19):1484-91. doi: 10.1001/archinternmed.2012.4261. Arch Intern Med. 2012. PMID: 22987143

9

Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.

Simmons BJ, Jenner KM, Delate T, Clark NP, Kurz D, Witt DM. Simmons BJ, et al. Among authors: clark np. Pharmacotherapy. 2012 Dec;32(12):1078-84. doi: 10.1002/phar.1139. Epub 2012 Oct 30. Pharmacotherapy. 2012. PMID: 23112110

10

Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty.

Clark NP, Cho SE, Delate T, Witt DM. Clark NP, et al. Thromb Res. 2013 May;131(5):390-5. doi: 10.1016/j.thromres.2013.02.017. Epub 2013 Mar 21. Thromb Res. 2013. PMID: 23522854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page